Moors & Cabot, Inc. Aptevo Therapeutics Inc. Put Options Transaction History
Moors & Cabot, Inc.
- $1.96 Billion
- Q3 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
About Aptevo Therapeutics Inc.
- Ticker APVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,090,640
- Market Cap $25.2M
- Description
- Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...